Tag Archives: BioAxone BioSciences

BioAxone receives fast track grant for Rho Kinase 2 inhibitor to improve outcomes in chronic SCI

CAMBRIDGE, Mass.–(BUSINESS WIRE)–BioAxone BioSciences, Inc. announced today the receipt of a Fast-Track grant (R44 NS110290-01) from the National Institute of Neurological Disorders and Stroke (NINDS), part of the National Institutes of Health, as part of the agency’s Small Business Innovation … Continue reading

Posted in Chronic Spinal Cord Injury Research, spinal cord injury research | Tagged ,